If you typed EPIC Research CRO into a search box, you are probably building a CRO shortlist. This article uses only what EPIC Research CRO publishes (epic-cro.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What EPIC Research CRO publishes
EPIC Research CRO is based in Coyoacán, Mexico City. Its who-we-are page describes full-range clinical development, regulatory and post-approval services for the pharmaceutical, biotech, medical device and nutraceutical industries in Latin America. Annette G. Ortiz Austin is Director General.
EPIC Research CRO vs bioaccess®
| Dimension | EPIC Research CRO | bioaccess® |
|---|---|---|
| Core focus | Mexico full-range CRO across product classes | First-in-human and early feasibility studies for medical devices |
| Geography | See provider site | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | See provider site | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If you need Mexican clinical development plus post-approval support under one roof, EPIC publishes that menu.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO on your list, including EPIC Research CRO, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Competitor facts from the EPIC Research CRO public pages linked above and public announcements, reviewed for bioaccess® competitive research (Aug–Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.
Leave a Reply